LNSR vs. DXR, ICU, DRIO, MODD, LUCD, APYX, MDAI, RVP, CODX, and FEMY
Should you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Daxor (DXR), SeaStar Medical (ICU), DarioHealth (DRIO), Modular Medical (MODD), Lucid Diagnostics (LUCD), Apyx Medical (APYX), Spectral AI (MDAI), Retractable Technologies (RVP), Co-Diagnostics (CODX), and Femasys (FEMY). These companies are all part of the "surgical & medical instruments" industry.
Daxor (NASDAQ:DXR) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, community ranking, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.
In the previous week, Daxor had 3 more articles in the media than LENSAR. MarketBeat recorded 6 mentions for Daxor and 3 mentions for LENSAR. Daxor's average media sentiment score of 0.96 beat LENSAR's score of 0.31 indicating that LENSAR is being referred to more favorably in the news media.
Daxor has higher earnings, but lower revenue than LENSAR.
LENSAR has a consensus price target of $8.00, indicating a potential upside of 135.50%. Given Daxor's higher possible upside, analysts clearly believe LENSAR is more favorable than Daxor.
Daxor has a net margin of 0.00% compared to Daxor's net margin of -34.11%. LENSAR's return on equity of 0.00% beat Daxor's return on equity.
1.3% of Daxor shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 60.6% of Daxor shares are held by company insiders. Comparatively, 38.5% of LENSAR shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Daxor has a beta of -0.49, meaning that its share price is 149% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.
LENSAR received 5 more outperform votes than Daxor when rated by MarketBeat users.
Summary
LENSAR beats Daxor on 7 of the 12 factors compared between the two stocks.
Get LENSAR News Delivered to You Automatically
Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools